HUP0102413A1 - Vektorok nukleinsavak bevitelére, ezeket tartalmazó készítmények és alkalmazásuk - Google Patents

Vektorok nukleinsavak bevitelére, ezeket tartalmazó készítmények és alkalmazásuk

Info

Publication number
HUP0102413A1
HUP0102413A1 HU0102413A HUP0102413A HUP0102413A1 HU P0102413 A1 HUP0102413 A1 HU P0102413A1 HU 0102413 A HU0102413 A HU 0102413A HU P0102413 A HUP0102413 A HU P0102413A HU P0102413 A1 HUP0102413 A1 HU P0102413A1
Authority
HU
Hungary
Prior art keywords
nucleic acid
compositions containing
transfer vectors
containing same
acid transfer
Prior art date
Application number
HU0102413A
Other languages
English (en)
Inventor
Carole Ciolina
Daniel Scherman
Pierre Wils
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9803573A external-priority patent/FR2776669B1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HUP0102413A1 publication Critical patent/HUP0102413A1/hu
Publication of HUP0102413A3 publication Critical patent/HUP0102413A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A találmány új vektorokra, valamint azok nukleinsavak beviteléretörténő alkalmazására vonatkozik. Részletesebben meghatározva, atalálmány tárgyát a nukleinsavakat specifikus sejtek vagysejtalkotórészek felé irányítani képes új vektorok képezik. Ó
HU0102413A 1998-03-24 1999-03-19 Nucleic acid transfer vectors, compositions containing same and uses HUP0102413A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9803573A FR2776669B1 (fr) 1998-03-24 1998-03-24 Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations
US8584898P 1998-05-18 1998-05-18
PCT/FR1999/000643 WO1999049067A1 (fr) 1998-03-24 1999-03-19 Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations

Publications (2)

Publication Number Publication Date
HUP0102413A1 true HUP0102413A1 (hu) 2001-10-28
HUP0102413A3 HUP0102413A3 (en) 2003-09-29

Family

ID=26234216

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102413A HUP0102413A3 (en) 1998-03-24 1999-03-19 Nucleic acid transfer vectors, compositions containing same and uses

Country Status (12)

Country Link
EP (1) EP1066396A1 (hu)
JP (1) JP2002507429A (hu)
KR (1) KR20010074456A (hu)
CN (1) CN1292827A (hu)
AU (1) AU758406B2 (hu)
BR (1) BR9909044A (hu)
CA (1) CA2323831A1 (hu)
HU (1) HUP0102413A3 (hu)
IL (1) IL138624A0 (hu)
NO (1) NO20004648L (hu)
PL (1) PL342944A1 (hu)
WO (1) WO1999049067A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1290156T3 (da) * 2000-05-26 2008-05-13 Centelion Oprensning af en tredobbelt spiralformation med et immobiliseret oligonukleotid
FR2871465B1 (fr) * 2004-06-15 2006-09-08 Centre Nat Rech Scient Cnrse Collections de composes tracables et leurs utilisations
WO2006133099A2 (en) * 2005-06-03 2006-12-14 The Cbr Institute For Biomedical Research, Inc. Sirna microbicides for preventing and treating viral diseases
US7795380B2 (en) 2006-06-02 2010-09-14 University Of Iowa Research Foundation Compositions and methods for nucleic acid delivery
JP6995768B2 (ja) * 2016-03-07 2022-02-21 クイデル カーディオバスキュラー インコーポレイテッド 免疫アッセイ対照およびその使用
RU2731513C2 (ru) * 2018-12-21 2020-09-03 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов NOS2, NOS3, VIP, KCNMA1, CGRP, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-NOS2, или Escherichia coli SCS110-AF/VTvaf17-NOS3, или Escherichia coli SCS110-AF/VTvaf17-VIP, или Escherichia coli SCS110-AF/VTvaf17-KCNMA1, или Escherichia coli SCS110-AF/VTvaf17-CGRP, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
WO2024206118A1 (en) * 2023-03-24 2024-10-03 Yarrow Therapeutics, Inc. Nuclear localization polypeptides and conjugates and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020698A1 (en) * 1991-05-17 1992-11-26 Uab Research Foundation Sequence specific dna binding drugs
US5670347A (en) * 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique

Also Published As

Publication number Publication date
IL138624A0 (en) 2001-10-31
BR9909044A (pt) 2000-12-05
KR20010074456A (ko) 2001-08-04
HUP0102413A3 (en) 2003-09-29
EP1066396A1 (fr) 2001-01-10
NO20004648D0 (no) 2000-09-18
NO20004648L (no) 2000-09-18
PL342944A1 (en) 2001-07-16
WO1999049067A1 (fr) 1999-09-30
CA2323831A1 (fr) 1999-09-30
JP2002507429A (ja) 2002-03-12
CN1292827A (zh) 2001-04-25
AU3406200A (en) 2000-12-14
AU758406B2 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
HUP0105052A2 (hu) Eljárások nukleinsav amplifikálására és szekvenálására
EP1032705A4 (en) PROBE ARRANGEMENTS AND THEIR USES FOR METHODS FOR DNA DISTINCTION
BR0010220A (pt) Compostos de pirimidinona
ATE224736T1 (de) Kombinationsprodukt, enthaltend eine nukleinsäure und eine substanz, die die extrazellulärematrix desorganisiert, zur verwendung in gentherapie
DK176687D0 (da) Lipolytiske enzymer og deres anvendelse i detergentkompositioner
DE69939169D1 (de) Aav5 vektoren und deren verwendung
DE69535352D1 (de) Expression der bazillus thuringiensis cry-proteine in pflanzen-plastiden
MXPA02002036A (es) Recombinacion especifica de la secuencia de adn en celulas eucarioticas.
IL133883A0 (en) Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents
CA2297911A1 (en) Substituted 6-phenylphenanthridines
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
HUP0001937A2 (hu) Új vegyületek, eljárás előállításukra és alkalmazásuk nukleinsavak sejtekbe való bevitelére
DE69522579D1 (de) Verwendung von spezifische lipolytische enzyme in reinigungsmitteln
MX9703445A (es) Material absorbente.
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
HUP0102413A1 (hu) Vektorok nukleinsavak bevitelére, ezeket tartalmazó készítmények és alkalmazásuk
TR199701202T1 (xx) Yeni hidroksimik asit t�revleri.
MXPA03004539A (es) Luciferasas aisladas y uso de las mismas.
DE59709864D1 (de) Verwendung von wasserlöslichen, nvi- oder nvpo-einheiten enthaltenden copolymerisaten als farbübertragungsinhibitoren in waschmitteln
EP1356076A4 (en) METHODS AND COMPOSITIONS FOR EXTRACTING PROTEINS FROM CELLS
AU5316999A (en) Use of nucleic acid molecules as antiviral agents
WO2001083822A3 (en) Use of representations of dna for genetic analysis
HUP0102455A3 (en) Novel nucleic acid transfer agents, compositions containing same and uses
PL348513A1 (en) Novel nucleic acid transferring agents, compositions containing them and uses
NO960271D0 (no) Tiokarbamoylforbindelser anvendt som mikrobiocider